Fortis Life Sciences acquires Abcore, a leader in nanobody technologies

Fortis Life Sciences has acquired Abcore, a San Diego, California, USA based antibody discovery platform specializing in nanobody technology. With the addition of Abcore, Fortis extends its capabilities into the antibody discovery market serving biopharma customers developing antibody and nanobody-based therapeutics.

Abcore is a powerful addition to the Fortis portfolio and deepens our antibody product and service capabilities. We are particularly optimistic about the potential of nanobody technologies in therapeutic and diagnostic applications. Our acquisition of Abcore aligns perfectly with Fortis’ goal of partnering with and investing in world-class life sciences companies seeking a strategic growth partner.”

Brian Kim, Chief Executive Officer, Fortis Life Sciences.

We are excited about accelerating Abcore’s growth as part of the Fortis family. Fortis shares our commitment to scientific discovery, innovation, and customer service and is the ideal partner for Abcore as we expand our technical capabilities and bring new products and services to market.”

David Barraclough, Chief Executive Officer, Abcore.

Our partnership with Fortis will provide Abcore with the commercial and operational infrastructure necessary for us to focus on developing high-quality products and better serving our customers.”

Jennifer Johnson, President, Abcore

Pivotal Scientific Ltd. acted as the exclusive corporate advisor to Abcore.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Fortis Life Sciences. (2023, March 30). Fortis Life Sciences acquires Abcore, a leader in nanobody technologies. News-Medical. Retrieved on July 21, 2024 from https://www.news-medical.net/news/20220303/Fortis-Life-Sciences-acquires-Abcore-a-leader-in-nanobody-technologies.aspx.

  • MLA

    Fortis Life Sciences. "Fortis Life Sciences acquires Abcore, a leader in nanobody technologies". News-Medical. 21 July 2024. <https://www.news-medical.net/news/20220303/Fortis-Life-Sciences-acquires-Abcore-a-leader-in-nanobody-technologies.aspx>.

  • Chicago

    Fortis Life Sciences. "Fortis Life Sciences acquires Abcore, a leader in nanobody technologies". News-Medical. https://www.news-medical.net/news/20220303/Fortis-Life-Sciences-acquires-Abcore-a-leader-in-nanobody-technologies.aspx. (accessed July 21, 2024).

  • Harvard

    Fortis Life Sciences. 2023. Fortis Life Sciences acquires Abcore, a leader in nanobody technologies. News-Medical, viewed 21 July 2024, https://www.news-medical.net/news/20220303/Fortis-Life-Sciences-acquires-Abcore-a-leader-in-nanobody-technologies.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.